These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 11117546

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.
    Pascual AM, Martínez-Bisbal MC, Boscá I, Valero C, Coret F, Martínez-Granados B, Marti-Bonmati L, Mir A, Celda B, Casanova B.
    Neurology; 2007 Jul 03; 69(1):63-7. PubMed ID: 17606882
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis.
    Gadea M, Martínez-Bisbal MC, Marti-Bonmatí L, Espert R, Casanova B, Coret F, Celda B.
    Brain; 2004 Jan 03; 127(Pt 1):89-98. PubMed ID: 14506072
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
    Narayanan S, Francis SJ, Sled JG, Santos AC, Antel S, Levesque I, Brass S, Lapierre Y, Sappey-Marinier D, Pike GB, Arnold DL.
    Neuroimage; 2006 Jan 15; 29(2):637-42. PubMed ID: 16126413
    [Abstract] [Full Text] [Related]

  • 8. [Total brain T2-hyperintense lesion-volume and the axonal damage in the normal-appearing white matter of brainstem in early lapsing-remitting multiple sclerosis].
    Pascual-Lozano AM, Martínez-Bisbal MC, Boscá-Blasco I, Valero-Merino C, Coret-Ferrer F, Martí-Bonmatí L, Martínez-Granados B, Celda B, Casanova-Estruch B.
    Rev Neurol; 2006 Jan 15; 45(8):468-73. PubMed ID: 17948212
    [Abstract] [Full Text] [Related]

  • 9. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
    Benedetti B, Rovaris M, Rocca MA, Caputo D, Zaffaroni M, Capra R, Bertolotto A, Martinelli V, Comi G, Filippi M.
    Mult Scler; 2009 Jul 15; 15(7):789-94. PubMed ID: 19465450
    [Abstract] [Full Text] [Related]

  • 10. Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis.
    Wolswijk G, Balesar R.
    Brain; 2003 Jul 15; 126(Pt 7):1638-49. PubMed ID: 12805111
    [Abstract] [Full Text] [Related]

  • 11. [Neuronal injury in multiple sclerosis].
    Correale J, Meli F, Ysrraelit C.
    Medicina (B Aires); 2006 Jul 15; 66(5):472-85. PubMed ID: 17137182
    [Abstract] [Full Text] [Related]

  • 12. Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy.
    Ruiz-Peña JL, Piñero P, Sellers G, Argente J, Casado A, Foronda J, Uclés A, Izquierdo G.
    BMC Neurol; 2004 Jun 10; 4():8. PubMed ID: 15191618
    [Abstract] [Full Text] [Related]

  • 13. Axonal transection in the lesions of multiple sclerosis.
    Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L.
    N Engl J Med; 1998 Jan 29; 338(5):278-85. PubMed ID: 9445407
    [Abstract] [Full Text] [Related]

  • 14. Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.
    Dubey P, Fatemi A, Barker PB, Degaonkar M, Troeger M, Zackowski K, Bastian A, Smith SA, Pomper MG, Moser HW, Raymond GV.
    Neurology; 2005 Jan 25; 64(2):304-10. PubMed ID: 15668429
    [Abstract] [Full Text] [Related]

  • 15. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
    Seewann A, Vrenken H, van der Valk P, Blezer EL, Knol DL, Castelijns JA, Polman CH, Pouwels PJ, Barkhof F, Geurts JJ.
    Arch Neurol; 2009 May 25; 66(5):601-9. PubMed ID: 19433660
    [Abstract] [Full Text] [Related]

  • 16. Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions.
    Evangelou N, DeLuca GC, Owens T, Esiri MM.
    Brain; 2005 Jan 25; 128(Pt 1):29-34. PubMed ID: 15548559
    [Abstract] [Full Text] [Related]

  • 17. [Spinal cord magnetic resonance imaging in multiple sclerosis: importance of determining degree of atrophy as a marker of disease course].
    De Seze J, Ayachi M, Stojkovic T, Gauvrit JY, Saint Michel T, Pruvo J, Vermersch P.
    Rev Neurol (Paris); 2000 May 25; 156(5):491-6. PubMed ID: 10844368
    [Abstract] [Full Text] [Related]

  • 18. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A, Rovaris M, Judica E, Sormani MP, Martinelli V, Comi G, Filippi M.
    Arch Neurol; 2007 Aug 25; 64(8):1163-8. PubMed ID: 17698707
    [Abstract] [Full Text] [Related]

  • 19. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
    Minagar A, Toledo EG, Alexander JS, Kelley RE.
    J Neuroimaging; 2004 Jul 25; 14(3 Suppl):5S-10S. PubMed ID: 15228754
    [Abstract] [Full Text] [Related]

  • 20. Sodium channel expression within chronic multiple sclerosis plaques.
    Black JA, Newcombe J, Trapp BD, Waxman SG.
    J Neuropathol Exp Neurol; 2007 Sep 25; 66(9):828-37. PubMed ID: 17805013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.